Application of dsRNA or modification thereof in preparation of tumor inhibitor
The invention discloses an application of a dsRNA (Double-stranded RNA) or a modification thereof in preparation of a tumor inhibitor. According to the application, the sequence of one strand of the dsRNA is SEQ ID No. 1 in the sequence table, and the sequence of the other strand of the dsRNA is SEQ...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
19.11.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention discloses an application of a dsRNA (Double-stranded RNA) or a modification thereof in preparation of a tumor inhibitor. According to the application, the sequence of one strand of the dsRNA is SEQ ID No. 1 in the sequence table, and the sequence of the other strand of the dsRNA is SEQ ID No. 2 in the sequence table; the modification of the dsRNA is the dsRNA modification obtained by being modified through the steps of A1), A2) or A3) as follows: A1) modifying 2'-OH of the ribose of the dsRNA; A2) modifying the phosphate diester bond, used for being connected with the ribotide, of the dsRNA; A3) modifying the cholesterol connected with the 5' end of the ribose of the dsRNA. Experimental results show that the 2'-OMe-dsRNA21 or the modification thereof can effectively inhibit tumor and tumor cells. |
---|---|
Bibliography: | Application Number: CN20141383877 |